The association between serum uric acid and renal damage in a community-based population: The Takahata study

Clinical and Experimental Nephrology

Volumn 17, Issue 4, 2013, Pages 541-548

  Suzuki, Kazuko ^a   Konta, Tsuneo ^a   Kudo, Kosuke ^a   Sato, Hiroko ^a   Ikeda, Ami ^a   Ichikawa, Kazunobu ^a   Ueno, Yoshiyuki ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Albuminuria; Tubular damage; Uric acid

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CREATININE; URIC ACID;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; KIDNEY INJURY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SEX DIFFERENCE; URIC ACID BLOOD LEVEL; URINALYSIS; URINARY ALBUMIN TO CREATININE RATIO; URINARY BETA2 MICROGLOBULIN TO CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS;

ADULT; AGED; ALBUMINURIA; BETA 2-MICROGLOBULIN; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; JAPAN; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY; URIC ACID;

EID: 84883309105     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0743-y     Document Type: Article

References (19)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
2. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404-10.
3. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthr Rheum. 2009;61:225-32.
4. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001;24:691-7.
5. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751-6.
6. World Health Organization, International Association for the Study of Obesity, International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney:Health Communications Australia Pty Limited; 2000. p. 15-21.
7. Kudo K, Konta T, Mashima Y, Ichikawa K, Takasaki S, Ikeda A, et al. The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study. Clin Exp Nephrol. 2011;15:2352-441.
8. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
9. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24-h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20:7-14.
10. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001;24:691-7.
11. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47:51-9.
12. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet. 1998;352:670-1.
13. Zhang W, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin Chem. 2009;55:2026-34.
14. Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, et al. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol. 2006;17:1791-5.
15. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90.
16. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553-62.
17. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282:F991-7.
18. Sánchez-Lozada LG, Tapia E, Santamaría J, Avila-Casado C, Soto V, Nepomuceno T, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67:237-47.
19. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004;65:1041-9.